The foremost geopolitical rivalry between the US and China is increasingly being played out through trade and economic ...

The company points to “emerging research” that shows GLP-1RA medications offer benefits beyond weight loss for patients ...

In the complex and challenging field of early-phase clinical trials, logistics specialists are vital. A recent podcast spoke ...

Hemab Therapeutics has concluded an oversubscribed Series C funding round, raising $157m to further develop therapies for ...

Fast growth for recently label-expanded drugs fuelled Novartis’ Q3 performance, despite headwinds from generic competition.

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

A sales probe from Organon's board has found evidence of wholesaler sales malpractice, resulting in Ali's resignation and a ...

Guardant Health and Zephyr AI have partnered to advance the discovery of novel cancer biomarkers, as more precise tumour ...

Real-world data (RWD) is an asset for vaccine research, safety monitoring, and education efforts, and is essential toward ...

Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...

Chugai has signed a definitive stock agreement to purchase Japan-based Renalys Pharma, augmenting its kidney disease ...

Novartis has signed an agreement for the acquisition of all the outstanding shares of US-based Avidity Biosciences.